Did You Join Us for the Webinar Nitrosamines: A Moving Target? Here’s Your Recap!

Our recent webinar, Nitrosamines: A Moving Target was a deep-dive into the issue of Nitrosamines impurities and how you can stay on top of the various evaluation requirements to remain compliant. During the webinar, Diana Van Geenhoven, our head of global compliance, Lena Ben Moha-Lerman, Senior Director of Lifecycle Management within Teva api’s R&D team

The Latest ESG Report Outlines Our Incredible Environmental and Social Efforts in 2020

At Teva api, we always remember how essential our work is to the wider community, and this was never more important than this past year, when the COVID-19 pandemic hit. As Teva’s Chairman, Dr Sol J Barer said, “At Teva, it reminded us of our responsibility to patients, our employees, communities and the planet. It

Regulations in Brazil are Changing

API regulation affairs in Brazil

On April 1st, 2020, Brazil’s ANVISA published new landmark regulations referring to active pharmaceutical ingredients (APIs). This new set of rules consists of three separate guidelines for local pharmaceutical segment stakeholders, known as “RDCs”. These are RDC 359/2020, RDC 361/2020 and RDC 362/2020, and they represent a complete overhaul of the API regulatory landscape in